Previous Page  3 / 11 Next Page
Information
Show Menu
Previous Page 3 / 11 Next Page
Page Background

Page 35

Notes:

allied

academies

Curr Trend Cardiol. 2017 | Volume 1 Issue 3

September 18-19, 2017 | Toronto, Canada

Annual Conference on

HEART DISEASES

Background:

Ganoderma lucidum

is a type of mushroom that

has been used for thousand years throughout Asia. It is known

to demonstrate numerous health benefiting properties

including antioxidant, antiinflammation, anticancer effects,

hypoglycaemic and blood cholesterol reducing properties.

This research was conducted to determine the efficacy

of

Ganoderma lucidum

polysaccharide peptides (PsP) as

antiinflammation, antioxidant, and endothelial protector in

cardiovascular disease.

Methods:

This is a true experimental study with pre- and

post-test design of 37 high risk patients of cardiovascular

disease based on the Framingham Risk Score that was

conducted for 3 months. They were advised to consume

PsP 3x250 mg as adjuvant to their previous medications.

They did some examines. Statistical analysis was conducted

using paired t-test for parametric data and Wilcoxon test for

nonparametric data.

Results:

From 37 patients we found that the administration

of PsP 3x250 mg could reduce total cholesterol level

from 219.46±49.49 to 201.43±81.63 (p=0.193). PsP

administration, however, decreased HDL cholesterol (HDL-C)

levels by 7.84±10.79 (p=0.000). The systolic blood pressure

decreased from130.14±43.37mmHg to 118.24±55.68mmHg

(p=0.109), and the diastolic blood pressure decreased from

80±25.74 mmHg to 73.24±33.85 mmHg (p=0.102). Despite a

great reduction of blood pressure to normal range, it was not

statistically significant. The reduction of anti-inflammatory

markers, interleukin 6 (IL-6), from 279.75±120.76 to

29.32±26.44 (p=0.000) and tumour necrosis factor alpha

(TNF alpha), from 13447.84 ± 2199.46 to 544.85 ± 292.06

(p=0.000) were significant.Malondialdehyde (MDA) level also

decreased significantly with PsP for 3 months (114.13±24.56

to 36.84±28.39, p=0.000). Circulating endothelial cell

(CEC) level significantly reduced (p=0.000) and endothelial

progenitor cell (EPC) level significantly increased (p=0.000).

Conclusions:

The administration of PsP

Ganoderma lucidum

for 3 months in high risk patients with hypertension can

reduce the blood pressure within normal range; improve

total cholesterol and LDL-C level and significantly pivotal role

as antiinflammation, antioxidant, and endothelial protector

in cardiovascular disease.

Speaker Biography

Djanggan Sargowo, MD, PhD, FIHA, FACC, FESC, FAPSC, FAsCC, FINASIM, is a Professor

at the University of Brawijaya, and is board certified in Internal Medicine and

Cardiovascular Disease. His clinical interests include management of ischemic heart

disease, congestive heart failure, hypertension, diabetes mellitus, dyslipidemia and

peripheral vascular disease. He received his MD from University of Gadjah Mada,

Yogyakarta, Indonesia. He received training in Internal Medicine at Airlangga University

and Cardiology at University of Indonesia. He received his PhD degree in Medicine from

University of Airlangga. In the past, Barry served as Head of Cardiology and Vascular

Department at Dr. Saiful Anwar General Hospital Malang and Director of Postgraduate

Program at University of Brawijaya. He is currently a Fellow of Indonesian Heart

Association, a Fellow of the American College of Cardiology, a Fellow of the European

Society of Cardiology, a Fellow of Asia Pacific Society of Cardiology, a Fellow of ASEAN

Federation of Cardiology, and a Fellow of Indonesian Society of Internal Medicine.

He serves as Director of Brawijaya University Teaching Hospital, Chairman of Malang

Molecular Biology Institute and as Chairman of Center for Degenerative Diseases,

Brawijaya University.

e:

djanggan@yahoo.com

Polysaccharide peptides of

Ganoderma lucidum

effects as antioxidant, antiinflammation, and

endothelial protector in high risk patients of atherosclerosis

Djanggan Sargowo, Olivia Handayani, Nizamuddin Ubaidillah, Adriyawan Widya, Vittryaturida, Kartika Siwi, Mirza Failasufi, Fadhli Ramadhan, Hesti

Wulandari, Yoga Waranugraha and Dinarsari Hayuning Putri

University of Brawijaya, Indonesia